Cancer News and Research

Latest Cancer News and Research

Grassley inquiry into fast-tracking of Avastin drug applications could hurt cancer drug development, patients

Sen. Chuck Grassley's (R-Iowa) request that the Government Accountability Office investigate whether FDA acted appropriately in granting "accelerated approval" to a cancer drug "will have a catastrophic effect on America's ability to develop new drugs," Mark Thornton, a former medical officer in FDA's Office of Oncology Drug Products and president of the Sarcoma Foundation of America, writes in a Wall Street Journal opinion piece.

30 May 2008

Self-assembled viruses

Viruses are true experts at importing genetic material into the cells of an infected organism. This trait is now being exploited for gene therapy, in which genes are brought into the cells of a patient to treat genetic diseases or genetic defects. Korean researchers have now made an artificial virus. As described in the journal Angewandte Chemie, they have been able to use it to transport both genes and drugs into the interior of cancer cells.

30 May 2008

Quality of life predicts cancer survival

Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center. The findings could mean that identifying patients with poor quality of life could also identify patients with particularly aggressive tumors.

30 May 2008

Spontaneous mutations widespread in non-familial schizophrenia

People with schizophrenia from families with no history of the illness were found to harbor eight times more spontaneous mutations - most in pathways affecting brain development - than healthy controls, in a study supported in part the National Institutes of Health?s (NIH) National Institute of Mental Health (NIMH). By contrast, no spontaneous mutations were found in people with schizophrenia who had family histories of the illness.

30 May 2008

Post-menopausal therapy to improve women's quality of life

A recent research work by the University of Granada advises post-menopausal women the use of Replacement Hormone Therapy (RHT) for at least five years.

29 May 2008

Body's baking soda used to catch cancer early

A chemical commonly called baking soda which is found naturally in the body could be used to detect cancer with magnetic resonance imaging, reveals a Cancer Research UK study published in Nature.

29 May 2008

Fireflies' glow helps researchers track cancer drug's effectiveness

The gene that allows fireflies to flash is helping researchers track the effectiveness of anti-cancer drugs over time.

29 May 2008

Cancer survivors are living "in limbo" with unmet needs for care

Many long-term survivors of cancer are not receiving the necessary symptom management that they require to help them live with the consequences of their disease, its treatment, or both, according to a leading professor of palliative medicine.

28 May 2008

Gulf Coast area children who lived in trailer units at risk for long-term illnesses

Tens of thousands of Gulf Coast area children who lived in trailer units provided by the Federal Emergency Management Agency after Hurricane Katrina in 2005 might have increased risk for long-term health problems, according to physicians and federal health officials, the AP/Denver Post reports.

28 May 2008

San Francisco Mayor rejects proposed budget cuts to HIV/AIDS services

San Francisco Mayor Gavin Newsom recently rejected proposed cuts to HIV/AIDS services in his fiscal year 2009 budget, the San Francisco Chronicle reports. According to the Chronicle, Newsom rejected a proposal by Mitch Katz, director of the San Francisco Department of Public Health, to cut $3 million of the $10 million the department allocates to 30 not-for-profit groups that provide HIV/AIDS services.

28 May 2008

Magnetic nanoparticles for cancer therapy

A measuring procedure developed in the Physikalisch-Technische Bundesanstalt (PTB) can help to investigate in some detail the behaviour of magnetic nanoparticles which are used for cancer therapy.

28 May 2008

New cancer stem cell identified behind metastatic tumors

The molecular profile of cancer stem cells that initiate metastatic colon tumors is significantly different from those responsible for primary tumors, according to new research from a team at Weill Cornell Medical College.

28 May 2008

Estrogen drives distinct, aggressive prostate cancer

Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers.

28 May 2008

Cancer Research UK creates 'crack teams' to solve cancer's greatest mysteries

World leading scientists are to be targeted by Cancer Research UK and its development and commercialisation arm Cancer Research Technology (CRT), in an effort to tackle some of cancer's most pressing scientific challenges.

28 May 2008

First patient enrolled in phase III study of Bevacizumab and Trastuzumab in early breast cancer

A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.

27 May 2008

Digital Healthcare appointed to major NHS Framework contract

NHS Connecting for Health, on behalf of the NHS, has appointed Digital Healthcare to the NHS Additional Supply Capability & Capacity (ASCC) Framework following open competition bids to provide additional capacity and capability in the supply of IT products and services to the NHS.

27 May 2008

Avoiding spleen removal for Cooley's anemia sufferers

Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia. Along with sickle-cell anemia, Cooley's anemia is the most commonly inherited disease in the world, affecting many people of Mediterranean descent, and 20 out of every 100,000 African-Americans. The World Health Organization estimates that between 50,000-100,000 children are born with the disease each year.

27 May 2008